Leukoencephalitis is an inflammatory lesion of the brain substance or its membranes, resulting from an infectious or viral lesion of the bone marrow. The source of inflammation can be various types of microorganisms, fungi or viruses. Treatment of leukoencephalitis should be comprehensive, combining specific antibacterial therapy and symptomatic treatment. The use of antivirals with a direct antitumor effect will in some cases make it possible to achieve a significant improvement in the course of the disease.
The etiology and pathogenesis of leukoencephalitis has a rather complex origin. Most cases of the disease are associated with HIV infection, neurosyphilis and inflammatory diseases. Leukocephalitis can also cause various infections, such as tuberculosis. According to statistics, young people aged 15-24 years suffer the most.
The clinical picture of leukoencephalitis has its own characteristics. The disease begins with a sharp increase in temperature to pyretic values (about 39°C) with sharp chills and a sharp headache. Along with headaches, patients may complain of weakness, nausea, vomiting and muscle spasms. Neurological disorders may occur: loss of consciousness, oculomotor disorders, convulsions, fever. Leukoencephalitis is characterized by damage to the white matter of the brain. In this case, slowly spreading ones dominate in the form of “wandering”
Leukoencephaloitis is a disease characterized by inflammatory changes in the brain. Etiology is hereditary determined. The inflammatory process is most often observed in the white matter of the brain. Pathological changes in leukoencephalitis are manifested by focal and diffuse processes in the brain substance: demyelination,